BCE Inc
BCE
TC Energy Corp
TRP
TELUS Corp
T
Enbridge Inc
ENB
The Toronto-Dominion Bank
TD
CA Stock MarketDetailed Quotes
MDCX Medicus Pharma Ltd
- 3.950
- 0.0000.00%
15min DelayMarket Closed Dec 12 16:00 ET
46.68MMarket Cap-3.32P/E (TTM)
0.000High0.000Low0Volume0.000Open3.950Pre Close0.00Turnover7.60052wk High0.00%Turnover Ratio11.82MShares2.55052wk Low-1.19EPS TTM15.45MFloat Cap7.600Historical HighLossP/E (Static)3.91MShs Float0.620Historical Low-2.572EPS LYR0.00%Amplitude--Dividend TTM9.27P/B1Lot Size--Div YieldTTM
About Medicus Pharma Ltd Company
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.
Company Profile
SymbolMDCX
Company NameMedicus Pharma Ltd
Founded2008
MarketTSX
Fiscal Year Ends12-31
Address100 King Street West Suite 3400, One First Canadian Place
CityToronto
CountryCAN
Zip CodeM5X 1A4
Phone+1 732 300-3046
Company Executives
- Name
- Position
- Salary
- Dr. Raza Bokhari
- Executive Chairman of the Board and Chief Executive Officer
- 43.51K
- Dr. Edward J. Brennan
- Chief Medical Officer
- 171.98K
- Erica Monaco, C.P.A.
- Chief Operating Officer
- --
- James P. Quinlan, C.P.A.
- Chief Financial Officer
- 215.72K
- Carolyn Bonner
- President
- --
- Barry Fishman
- Independent Director
- 20.16K
- Dr. Larry Kaiser
- Independent Director
- 20.16K
- William L. Ashton
- Independent Director
- 17.66K
- Robert J. Ciaruffoli
- Lead Independent Director
- 23.91K
- Frank Lavelle
- Independent Director
- 20.16K
- Dr. Sara R. May
- Independent Director
- --
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.